DOCSLIB.ORG

Mercury Survey College of Pharmacy

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mercury Survey College of Pharmacy Appendix A - Survey Tools ACADEMIC LABORATORY MERCURY MINIMALIZATION | SECURED DOCUMENT Academic Affairs Laboratory Safety Mercury Survey College of Pharmacy Number: AALSSD 2-30-3500 CP-F01 Author: Anne Hawkins Effective Date: Revision Date: Accepted/ Issued: Name of individual filling out survey: Title: Phone: Please indicate if the following mercury sources are located or used in your Department I. Equipment: Barometers Batteries Centrifuges Fever Thermometers Hood Manometer Sphygmomanometers Thermostats Other II. Chemicals/Staining Solutions & Preservatives: Mercury iodide Mercury (I) Bromide Mercury (I) Carbonate Mercury (I) Chloride Mercury (I) Chromate Mercury (I) Dichromate Mercury (I) Nitrate Mercury (I) Nitrate Mercury (I) Oxide Mercury (I) Sulfate Mercury (I) Sulfide Mercury (II) Acetate Mercury (II) Ammonium Thoocyanate Mercury (II) Bromate Mercury (II) Bromide Mercury (II) Carbonate Mercury (II) Chlorate Mercury (II) Chloride Mercury (II) Chromate Mercury (II) Dichromate Mercury (II) Hydrogen Carbonate Mercury (II) Hydroxide Mercury (II) Iodate Mercury (II) Nitrate Mercury (II) Nitrate Monohydrate Mercury (II) Nitrite Mercury (II) Oxide Mercury (II) Nitride Mercury (II) Phosphate Mercury (II) Sulfate Mercury (II) Sulfide Mercury (II) Thiosulfate Commercial Chemical Products Acetate Acetic acid Alum Ammonium reagent/Stone analysis kit Antibody test kits Antigens Buffers Chloride Diluents Ethanol Fixatives Immunoelectrophoresis reagents Immunofixationphoresis reagents: Immu-sal Potassium hydroxide Shigella bacteria Sodium hypochlorite Sulfuric acid Thimerosal T Tracer kits Urine analysis reagents Other III. Drug & Biologic Products- Thimerosal: Akorn Inc. AK Spore Ophthalmic Solution AK Spore HC Ophthalmic Combo Drops Fluoracaine Ophthalmic Solution AK Spore HC Otic Suspension Alcon Laboratories Profenal 1% Ophthalmic Solution Adsorbonac 2% Ophthalmic Solution Adsorbonac 5% Ophthalmic Solution Allergan America Ocufen Ophthalmic Solution Poly Pred Ophthalmic Suspension Allergan Inc. Blephamide SOP Ophthalmic Ointment Bleph-10 Ophthalmic Ointment 10% FML SOP Ophthalmic Ointment 0.1% Poly Pred Ophthalmic Suspension Altaire Pharmaceuticals Nasal Relief 12 Hour Spray American Assn. Retired Oxymetazoline Nasal Spray Persons American International Thimersol (bulk chemical) Chemical Thimerosal USP 97% (bulk chemical) American Pharmaceutical 12 Hour nasal Solution Appletree Markets Long Lasting Nasal Spray Bausch & Lomb Flurbiprofen Sodium Ophthalmic Solution Neomycin & Polymyxin B Sulfates & Gramicidin Ophthalmic Solution Neomycin & Polymyxin B Sulfates & Hydrocortisone Otic Suspension Sulfacetamide Sodium & Prednisolone Sodium Phosphate Ophthalmic Solution 10%/.23% Bristol-Myers Squibb Fungizone Solution Fungizone Cream C.O. Truxton Inc. Bio-Cot Otic Suspension Decongest Nasal Spray Cheshire Pharmaceutical Otocort Otic Suspension Ocutricin Ophthalmic Solution Sulfapred Ophthalmic Solution CVS Nasal Spray Pump CVS Revco DS Inc. 12 Hour Decongestant Pump Nasal Spray Dolder Ltd. Thimerosal (bulk chemical) Dorex International Corp. Long Acting Nasal Spray Drug Guild Distributors Long Acting Nasal Spray Kolex LA DRX Pharmaceutical Blephamide Ophthalmic Ointment Cortisporin Ophthalmic Suspension Neomycin Polymyxin B Sulfates Hydrocortisone Ophthalmic Suspension Neomycin Polymyxin B Hydrocortisone Otic Suspension Neomycin Polymyxin B Gramicidin Ophthalmic Solution Vasocidin Ophthalmic Solution Colymycin S Otic Suspension Pediotic Otic Solution Dysers Sal Thimerosal (bulk chemical) Family Independent 12 Hour Nasal Decongestant Spray Pharmacy Long Acting Nasal Spray Farm Fresh Inc. Hemerrhoid Relief Ointment Fays Drug Services 12 Hour Nasal Spray Pump Federated Foods Long Acting Nasal Spray Fleming Companies 12 Hour Nasal Spray Foxmeyer Drug Co. Nasal Spray Pump Global Source Nasin Long Acting Nasal Spray Harco Drug Mercurochrome Aqueous Solution King Pharmaceuticals Cortisporin Ophthalmic Suspension Neosporin Ophthalmic Suspension Viroptic Ophthalmic Solution Neomycin Polymyxon B Sulfates Hydrocortisone Otic Suspension Pediotic Suspension Cortisporin Otic Suspension Kinray Oxymetazoline Nasal Spray Laboratori Derivati Adrenal Cortex Injection Leader 12 Hour Nasal Spray Nasal Pump Spray LS Raw Materials Ltd. Mercurochrome NF 12 100% (bulk chemical) Major Pharmaceuticals Sulfacetamide Sodium & Prednisolone Sodium Phosphate Ophthalmic Solution Cortomycin Otic Suspension Neocidin Ophthalmic Solution Martin Surgical Supply Testosterone Injection Suspension 50 mg Testosterone Injection Suspension 100 mg Mays Drug Stores Hemerrhoid Relief Ointment Medalist Laboratories Long Lasting Nasal Spray Pump Meyers Supply Inc. Long Acting Nasal Spray Navresso Long Acting Nasal Spray Omicron Quimica SA Thimerosal USP 97% (bulk chemical) Parade (Grocer’s Supply) Oxymetazoline Nasal Spray Parkedale Pharmaceuticals Coly-Mycin S Otic Suspension Pay N Save Corp. Decongestant Nasal Spray Pharmedix Bleph 10 Ophthalmic Solution 10% Viroptic Ophthalmic Solution 1% Blephamide Ophthalmic Ointment Triple Antibiotic Ophthalmic Solution Colymycin S Otic Solution Neo Poly with HC Otic Suspension Physicians Total Care Inc. Neomycin Polymyxin B Sulfates Hydrocortisone Ophthalmic Suspension Viroptic Ophthalmic Solution Cortisporin Ophthalmic Suspension Ocufen Ophthalmic Solution Vasocidin Ophthalmic Solution Ping On Ointment Co. Ltd. Ping On Topical Ointment Prime Natural Health 12 Hour Nasal Spray Primedics Laboratories Testosterone Injection Suspension 50 mg Publix Inc. Long Acting Nasal Spray Qualitest Pharmaceuticals Nasal Spray Solution Antibiotic HC Otic Suspension RDS Acquisition Corp. 12 Hour Nasal Spray Republic Drug Co. 12 Hour Nasal Spray Schering-Plough Animal Gentocin Durafilm Ophthalmic Solution (for dogs ony) Health Scrivner Inc. Hemorrhoid Relief Ointment Sight Pharmaceuticals Neomycin Polymyxin B Sulfates Hydrocortisone Otic Suspension Sulfacetamid Sodium & Prednisolone Sodium Phosphate Ophthalmic Solution Spectrum Quality Products Merbromin (bulk chemical) Thimerosal (bulk chemical) Super Laboratories Long Acting Nasal Spray Taro Laboratories Taro Nasal Decongestant Spray Teral Laboratories Oticin HC Otic Suspension Thames Pharmacal Co. 12 Hour Nasal Spray Thrifty Payless Inc. Nasal Spray Pump Formula Decongestant Nasal Spray Pump United Research Labs Antibiotic Ear Suspension Neomycin Polymyxin B Sulfates Gramicidin Ophthalmic Solution US Ophthalmics Fluorescein Sodium Ophthalmic Solution Sulf-10 Ophthalmic Solution Vasocidin Ophthalmic Solution Phenylephrine HC1 Ophthalmic Solution 10% USCO Logistics Procofen Ophthalmic Solution Profenal Ophthalmic Solution VEDCO Inc. Tribiotic Ophthalmic Solution Waldbaum Inc. Hemorrhoid Ointment Weeks and Leo Co. Inc. Long Acting Nasal Spray Solution Whitehall-Robins Dristan 12-Hour Nasal Spray The following are synonyms and trade names for Thimerosal: Aeroaid Merzonin sodium Curativ Merzonin, sodium salt Ethyl (2-mercaptobenzoato-S) mercury sodium Nosemack salt [(o-carboxyphenyl)thio] Ethyl mercury sodium Sodium ethylmercurithiosalicylate salt o-(Ethylmercurithio) benzoic acid sodium salt Mercurothiolate Elcide 75 Mertorgan Elicide Merfamin Estivin Septicol Ethylmercurithiosalicyclic acid, sodium salt SET Ethylmercurithiosalicylate sodium Sodium ethylmercuric thiosalicylate Ethylmercurithiosalicyclic sodium salt Sodium ethylmercurithiosalicylate Mercurothiolate Sodium merthiolate Mercurate(1-), {ethyl[o-mercaptobenzoato(2-)]-,} Sodium o-(ethylmercurithio) benzoate sodium Mercurate(1-),{ethyl[2-mercaptobenzoato(2-)- Sodium salt of 2-(carboxyphenyl) thioethylmercury O,S]-,} sodium Mercurochrome® Sodium 2-(ethylmercurithio) benzoate Thimerosal Mercural Thimerosal solution Thimerosalate Mercury, ethyl(hydrogen o-mercaptobenzoato)-, Thimerosal sodium salt Mercury, ethyl(2-mercaptobenzoato-S)-sodium Thimerosal solution salt Mercury {[(ocarboxyphenyl)thio]ethyl}-sodium Thimersalate salt Thiomerosal Merphol Thiomersalate Merseptyl (VAN) Thiomersalate Merthiolate® Thiomersal Merthiolate salt Thiomersalan Merthiolate sodium Vitasepto List all formulated mercury (added products) including but not limited to: acids, alcohols, bleach (sodium hypochlorite), material used for cleaning, in maintenance, or for disinfection, and reagents. IV. Facility Related Systems/ Equipment & Supplies Analytical Instruments Commercial Cleaning Agents Bleach Detergents Scouring powders Soaps Lamps Bilirubin blue Cold cathode Fluorescent General purpose Germicidal Highoutput Hot cathode Mercury vapor ultraviolet spectral Metal halide high pressure sodium vapor Neon (all colors except red, orange, and pink) Slimline V. Please list any other possible sources of mercury or any other materials that could be a concern for mercury pollution. VI. Have you considered or adopted mercury free alternatives for any of the products listed above? Please explain. Please complete the following section on practices at your facility: Does your facility have a policy on purchasing mercury containing products? Yes No If yes, please attach a copy of the policy. Do you currently require disclosure by vendors of mercury concentrations in solutions? Yes No What is the current procedure for disposal of medical waste? Autoclave Incineration Other.
Load more

Recommended publications
  • Chemical Disinfectants for Biohazardous Materials (3/21)
    Safe Operating Procedure (Revised 3/21) CHEMICAL DISINFECTANTS FOR BIOHAZARDOUS MATERIALS ____________________________________________________________________________ Chemicals used for biohazardous decontamination are called sterilizers, disinfectants, sanitizers, antiseptics and germicides. These terms are sometimes equivalent, but not always, but for the purposes of this document all the chemicals described herein are disinfectants. The efficacy of every disinfectant is based on several factors: 1) organic load (the amount of dirt and other contaminants on the surface), 2) microbial load, 3) type of organism, 4) condition of surfaces to be disinfected (i.e., porous or nonporous), and 5) disinfectant concentration, pH, temperature, contact time and environmental humidity. These factors determine if the disinfectant is considered a high, intermediate or low-level disinfectant, in that order. Prior to selecting a specific disinfectant, consider the relative resistance of microorganisms. The following table provides information regarding chemical disinfectant resistance of various biological agents. Microbial Resistance to Chemical Disinfectants: Type of Microbe Examples Resistant Bovine spongiform encephalopathy (Mad Prions Cow) Creutzfeldt-Jakob disease Bacillus subtilis; Clostridium sporogenes, Bacterial Spores Clostridioides difficile Mycobacterium bovis, M. terrae, and other Mycobacteria Nontuberculous mycobacterium Poliovirus; Coxsackievirus; Rhinovirus; Non-enveloped or Small Viruses Adenovirus Trichophyton spp.; Cryptococcus sp.;
    [Show full text]
  • EH&S COVID-19 Chemical Disinfectant Safety Information
    COVID-19 CHEMICAL DISINFECTANT SAFETY INFORMATION Updated June 24, 2020 The COVID-19 pandemic has caused an increase in the number of disinfection products used throughout UW departments. This document provides general information about EPA-registered disinfectants, such as potential health hazards and personal protective equipment recommendations, for the commonly used disinfectants at the UW. Chemical Disinfectant Base / Category Products Potential Hazards Controls ● Ethyl alcohol Highly flammable and could form explosive Disposable nitrile gloves Alcohols ● ● vapor/air mixtures. ● Use in well-ventilated areas away from o Clorox 4 in One Disinfecting Spray Ready-to-Use ● May react violently with strong oxidants. ignition sources ● Alcohols may de-fat the skin and cause ● Wear long sleeve shirt and pants ● Isopropyl alcohol dermatitis. ● Closed toe shoes o Isopropyl Alcohol Antiseptic ● Inhalation of concentrated alcohol vapor 75% Topical Solution, MM may cause irritation of the respiratory tract (Ready to Use) and effects on the central nervous system. o Opti-Cide Surface Wipes o Powell PII Disinfectant Wipes o Super Sani Cloth Germicidal Wipe 201 Hall Health Center, Box 354400, Seattle, WA 98195-4400 206.543.7262 ￜ fax 206.543.3351ￜ www.ehs.washington.edu ● Formaldehyde Formaldehyde in gas form is extremely Disposable nitrile gloves for Aldehydes ● ● flammable. It forms explosive mixtures with concentrations 10% or less ● Paraformaldehyde air. ● Medium or heavyweight nitrile, neoprene, ● Glutaraldehyde ● It should only be used in well-ventilated natural rubber, or PVC gloves for ● Ortho-phthalaldehyde (OPA) areas. concentrated solutions ● The chemicals are irritating, toxic to humans ● Protective clothing to minimize skin upon contact or inhalation of high contact concentrations.
    [Show full text]
  • For Peer Review Only - Page 1 of 27 BMJ Open
    BMJ Open BMJ Open: first published as 10.1136/bmjopen-2015-010387 on 4 April 2016. Downloaded from FALSIFIED MEDICINES IN PERU: A Retrospective Review (1997-2014). ForJournal: peerBMJ Open review only Manuscript ID bmjopen-2015-010387 Article Type: Research Date Submitted by the Author: 27-Oct-2015 Complete List of Authors: Medina, Edwin; University of Barcelona - Faculty of Pharmacy, Department of Pharmacy and Pharmaceutical Technology Bel, Elvira; University of Barcelona - Faculty of Pharmacy, Department of Pharmacy and Pharmaceutical Technology Suñé, Josep María; University of Barcelona - Faculty of Pharmacy, Department of Pharmacy and Pharmaceutical Technology <b>Primary Subject Public health Heading</b>: Secondary Subject Heading: Global health, Epidemiology, Health policy, Health services research Keywords: Safety, Falsified, Medicines, Alerts, counterfeit, Drugs http://bmjopen.bmj.com/ on September 24, 2021 by guest. Protected copyright. For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml Page 1 of 27 BMJ Open BMJ Open: first published as 10.1136/bmjopen-2015-010387 on 4 April 2016. Downloaded from 1 2 3 FALSIFIED MEDICINES IN PERU: A Retrospective Review (1997-2014). 4 5 6 7 Authors: Edwin Medina1, Elvira Bel1, Josep María Suñé1 8 9 10 11 12 Affiliations: 13 14 15 1. DepartmentFor of peerPharmacy and review Pharmaceutical onlyTechnology, Faculty of 16 Pharmacy, University of Barcelona, Spain 17 18 19 20 Corresponding author: 21 22 Edwin Salvador Medina Vargas 23 24 Department of Pharmacy and Pharmaceutical Technology 25 Faculty of Pharmacy 26 University of Barcelona 27 Joan XXIII, s/n, 08028 Barcelona 28 29 Spain 30 Email: [email protected] 31 32 33 http://bmjopen.bmj.com/ 34 Keywords: Safety, Falsified, Medicines, Alerts, counterfeit, Drugs 35 36 37 38 39 Word Count 40 41 Abstract: 298 on September 24, 2021 by guest.
    [Show full text]
  • Hydroxy- -Methylbutyrate (Hmb)
    (19) *EP003373740B1* (11) EP 3 373 740 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A23K 10/10 (2016.01) A23L 33/10 (2016.01) 24.02.2021 Bulletin 2021/08 (86) International application number: (21) Application number: 16864978.8 PCT/US2016/061278 (22) Date of filing: 10.11.2016 (87) International publication number: WO 2017/083487 (18.05.2017 Gazette 2017/20) (54) COMPOSITIONS AND METHODS OF USE OF -HYDROXY- -METHYLBUTYRATE (HMB) AS AN ANIMAL FEED ADDITIVE ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG VON BETA-HYDROXY-BETA-METHYLBUTYRAT (HMB) ALS FUTTERZUSATZ COMPOSITIONS ET PROCÉDÉS D’UTILISATION DE -HYDROXY- -MÉTHYLBUTYRATE (HMB) COMME ADDITIF D’ALIMENT POUR ANIMAUX (84) Designated Contracting States: • BAIER, Shawn AL AT BE BG CH CY CZ DE DK EE ES FI FR GB Polk City, Iowa 50226 (US) GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR (74) Representative: Evans, Jacqueline Gail Victoria Marches Intellectual Property Limited (30) Priority: 10.11.2015 US 201562253428 P Wyastone Business Park Wyastone Leys (43) Date of publication of application: Ganarew 19.09.2018 Bulletin 2018/38 Monmouth NP25 3SR (GB) (73) Proprietor: Metabolic Technologies, Inc. (56) References cited: Ames, IA 50010 (US) WO-A1-2004/037010 US-A- 5 028 440 US-A- 5 087 472 US-A- 5 087 472 (72) Inventors: US-A- 6 103 764 US-A1- 2014 249 223 • FULLER, John US-A1- 2015 025 145 Zearing, Iowa 50278 (US) • RATHMACHER, John Story City, Iowa 50248 (US) Note: Within nine months of the publication of the mention of the grant of the European patent in the European Patent Bulletin, any person may give notice to the European Patent Office of opposition to that patent, in accordance with the Implementing Regulations.
    [Show full text]
  • Selling Mercury Cosmetics and Pharmaceuticals (W-Hw4-22)
    www.pca.state.mn.us Selling mercury cosmetics and pharmaceuticals Mercury-containing skin lightening creams, lotions, soaps, ointments, lozenges, pharmaceuticals and antiseptics Mercury is a toxic element that was historically used in some cosmetic, pharmaceutical, and antiseptic products due to its unique properties and is now being phased out of most uses. The offer, sale, or distribution of mercury-containing products is regulated in Minnesota by the Minnesota Pollution Control Agency (MPCA). Anyone offering a mercury-containing product for sale or donation in Minnesota is subject to these requirements, whether a private citizen, collector, non-profit organization, or business. Offers and sales through any method are regulated, whether in a store or shop, classified advertisement, flea market, or online. If a mercury-containing product is located in Minnesota, it is regulated, regardless of where a purchaser is located. Note: This fact sheet discusses the requirements and restrictions of the MPCA. Cosmetics and pharmaceuticals may also be regulated for sale whether they contain mercury or not by other state or federal agencies, including the Minnesota Board of Pharmacy and the U.S. Food & Drug Administration. See More information on page 2. What are the risks of using mercury-containing products? Use of mercury-containing products can damage the brain, kidneys, and liver. Children and pregnant women are at increased risk. For more information about the risks of mercury exposure, visit the Minnesota Department of Health. See More information on the page 2. If you believe you have been exposed to a mercury-containing product, contact your health care provider or the Minnesota Poison Control Center at 1-800-222-1222.
    [Show full text]
  • Amoxicillin in Water: Insights Into Relative Reactivity, Byproduct Formation, and Toxicological Interactions During Chlorination
    applied sciences Article Amoxicillin in Water: Insights into Relative Reactivity, Byproduct Formation, and Toxicological Interactions during Chlorination Antonietta Siciliano 1 , Marco Guida 1 , Giovanni Libralato 1 , Lorenzo Saviano 1, Giovanni Luongo 2 , Lucio Previtera 3, Giovanni Di Fabio 2 and Armando Zarrelli 2,* 1 Department of Biology, University of Naples Federico II, 80126 Naples, Italy; [email protected] (A.S.); [email protected] (M.G.); [email protected] (G.L.); [email protected] (L.S.) 2 Department of Chemical Sciences, University of Naples Federico II, 80126 Naples, Italy; [email protected] (G.L.); [email protected] (G.D.F.) 3 Associazione Italiana per la Promozione delle Ricerche su Ambiente e Salute umana, 82030 Dugenta, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-08-167-4472 Abstract: In recent years, many studies have highlighted the consistent finding of amoxicillin in waters destined for wastewater treatment plants, in addition to superficial waters of rivers and lakes in both Europe and North America. In this paper, the amoxicillin degradation pathway was investigated by simulating the chlorination process normally used in a wastewater treatment plant to reduce similar emerging pollutants at three different pH values. The structures of 16 isolated Citation: Siciliano, A.; Guida, M.; degradation byproducts (DPs), one of which was isolated for the first time, were separated on a Libralato, G.; Saviano, L.; Luongo, G.; C-18 column via a gradient HPLC method. Combining mass spectrometry and nuclear magnetic Previtera, L.; Di Fabio, G.; Zarrelli, A. resonance, we then compared commercial standards and justified a proposed formation mechanism Amoxicillin in Water: Insights into beginning from the parent drug.
    [Show full text]
  • A Screening-Based Approach to Circumvent Tumor Microenvironment
    JBXXXX10.1177/1087057113501081Journal of Biomolecular ScreeningSingh et al. 501081research-article2013 Original Research Journal of Biomolecular Screening 2014, Vol 19(1) 158 –167 A Screening-Based Approach to © 2013 Society for Laboratory Automation and Screening DOI: 10.1177/1087057113501081 Circumvent Tumor Microenvironment- jbx.sagepub.com Driven Intrinsic Resistance to BCR-ABL+ Inhibitors in Ph+ Acute Lymphoblastic Leukemia Harpreet Singh1,2, Anang A. Shelat3, Amandeep Singh4, Nidal Boulos1, Richard T. Williams1,2*, and R. Kiplin Guy2,3 Abstract Signaling by the BCR-ABL fusion kinase drives Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) and chronic myelogenous leukemia (CML). Despite their clinical activity in many patients with CML, the BCR-ABL kinase inhibitors (BCR-ABL-KIs) imatinib, dasatinib, and nilotinib provide only transient leukemia reduction in patients with Ph+ ALL. While host-derived growth factors in the leukemia microenvironment have been invoked to explain this drug resistance, their relative contribution remains uncertain. Using genetically defined murine Ph+ ALL cells, we identified interleukin 7 (IL-7) as the dominant host factor that attenuates response to BCR-ABL-KIs. To identify potential combination drugs that could overcome this IL-7–dependent BCR-ABL-KI–resistant phenotype, we screened a small-molecule library including Food and Drug Administration–approved drugs. Among the validated hits, the well-tolerated antimalarial drug dihydroartemisinin (DHA) displayed potent activity in vitro and modest in vivo monotherapy activity against engineered murine BCR-ABL-KI–resistant Ph+ ALL. Strikingly, cotreatment with DHA and dasatinib in vivo strongly reduced primary leukemia burden and improved long-term survival in a murine model that faithfully captures the BCR-ABL-KI–resistant phenotype of human Ph+ ALL.
    [Show full text]
  • HIV-2 BLOT 1.2 Instructions for Use
    HIV-2 BLOT 1.2 Instructions For Use FOR RESEARCH USE ONLY NOT FOR USE IN DIAGNOSTIC PROCEDURES REVISION DATE: 2017/05 Note Changes Highlighted MAC0012-ENG-1 (18 Tests): 11022-018 (36 Tests): 11022-036 NAME AND INTENDED USE The MP DIAGNOSTICS HIV-2 BLOT 1.2 is a qualitative enzyme immunoassay for in-vitro detection of specific antibodies to HIV-2 in human serum or plasma. This test kit is supplied for research purposes only. It is not intended for use in the diagnosis or prognosis of disease. In particular, this test cannot be used to evaluate blood specimens for the purposes of donor screening or as a confirmatory diagnostic. INTRODUCTION The MP Diagnostics HIV-2 BLOT 1.2 kit is intended as a supplemental antibody assay for Research Use Only. Human Immunodeficiency Virus Type 2 (HIV-2) infection was first described in 1985 in asymptomatic prostitutes from Senegal. The virus was subsequently isolated in 1986 from patients with AIDS-like symptoms in Guinea Bissau and Cape Verde. HIV-2 is related to, but distinct from HIV-1, the prototype AIDS virus. As such HIV-2 has many molecular, biological and serological similarities with HIV-1. Reports have shown that the infection is not limited to Africa and that HIV-2 seropositive individuals have been identified in Europe and the United States. DESCRIPTIONS OF SYMBOLS USED The following are graphical symbols used in or found on MP Diagnostics products and packaging. These symbols are the most common ones appearing on medical devices and their packaging. Some of the common symbols are explained in more detail in European Standard BS EN 980:2008 and International Standard ISO 15223-1:2007.
    [Show full text]
  • United States Patent (19) 11 Patent Number: 6,039,940 Perrault Et Al
    US0060399.40A United States Patent (19) 11 Patent Number: 6,039,940 Perrault et al. (45) Date of Patent: Mar. 21, 2000 54) INHERENTLY ANTIMICROBIAL 5,563,056 10/1996 Swan et al.. QUATERNARY AMINE HYDROGEL WOUND 5,599.321 2/1997 Conway et al.. DRESSINGS 5,624,704 4/1997 Darouiche et al.. 5,670.557 9/1997 Dietz et al.. 75 Inventors: James J. Perrault, Vista, Calif.; 5,674.561 10/1997 Dietz et al.. Cameron G. Rouns, Pocatello, Id. 5,800,685 9/1998 Perrault. FOREIGN PATENT DOCUMENTS 73 Assignee: Ballard Medical Products, Draper, Utah 92/06694 4/1992 WIPO. WO 97/14448 4/1997 WIPO. 21 Appl. No.: 09/144,727 OTHER PUBLICATIONS 22 Filed: Sep. 1, 1998 I. I. Raad, “Vascular Catheters Impregnated with Antimi crobial Agents: Present Knowledge and Future Direction,” Related U.S. Application Data Infection Control and Hospital Epidemiology, 18(4): 63 Continuation-in-part of application No. 08/738,651, Oct. 28, 227–229 (1997). 1996, Pat. No. 5,800,685. R. O. Darouiche, H. Safar, and I. I. Raad, “In Vitro Efficacy of Antimicrobial-Coated Bladder Catheters in Inhibiting 51) Int. Cl." .......................... A61K31/785; A61F 13/00 Bacterial Migration along Catheter Surface,” J. Infect. Dis., 52 U.S. Cl. ..................................... 424/78.06; 424/78.08; 176: 1109-12 (1997). 424/78.35; 424/78.37; 424/443; 424/445 W. Kohen and B. Jansen, “Polymer Materials for the Pre 58 Field of Search ..................................... 424/443, 445, vention of Catheter-related Infections.” Zbl Bakt., 283: 424/78.06, 78.07, 78.08, 78.35, 78.37 175-186 (1995).
    [Show full text]
  • Sodium Hypochlorite
    SODIUM HYPOCHLORITE What is SODIUM HYPOCHLORITE? Sodium hypochlorite is a liquid with an odor of chlorine. Usually it is clear but some solutions are greenish to yellow in color. Other names for sodium hypochlorite include Clorox , bleach, liquid bleach, sodium oxychloride, Javex, antiformin, showchlon, Chlorox, B-K, Carrel-Dakin Solution, Chloros, Dakin’s Solution, hychlorite, Javelle Water, Mera Industries 2MOm≥B, Milton, modified Dakin’s Solution, Piochlor, and 13% active chlorine. Where can sodium hypochlorite be found and how is it used? Sodium hypochlorite is mainly used as a bleaching agent or disinfectant. A disinfectant kills bacteria that can carry diseases. It is found in consumer and commercial bleaches, cleaning solutions, and disinfectants for drinking water, wastewater and swimming pools. How can people be exposed to sodium hypochlorite? You could be exposed to sodium hypochlorite through: Breathing fumes while using products containing sodium hypochlorite. Drinking water from public drinking water supplies where these chemicals were added to kill bacteria. You could also be exposed by drinking sodium hypochlorite by accident. Touching sodium hypochlorite if gloves are not worn when using products containing it. Eye Contact by splashing sodium hypochlorite during use. People who work where sodium hypochlorite is used to bleach paper and textiles may have slightly higher levels of exposure in all of the above areas. How does sodium hypochlorite work and how can it affect my health? Sodium hypochlorite is a corrosive substance, meaning that it will eat away at materials it contacts. Accidental sodium hypochlorite poisoning can be deadly. Severe injuries can occur to the mouth, throat, esophagus and stomach.
    [Show full text]
  • Kinetic Studies on Oxidative Dissolution of Elemental Mercury in Aqueous Sodium Hypochlorite
    International Journal of Environmental Science and Development, Vol. 7, No. 7, July 2016 Kinetic Studies on Oxidative Dissolution of Elemental Mercury in Aqueous Sodium Hypochlorite S. Bandyopadhyay, S. Chakraborty, D. B. Zaini, and S. Bhattacharjee mercury and second order reaction kinetics was observed Abstract—Aqueous sodium hypochlorite is often used to between elemental mercury and free chlorine. detoxify solid wastes containing elemental mercury and its Solid wastes are often treated with aqueous sodium compounds by oxidative dissolution of mercury in the form of a hypochlorite to remove mercury and its compounds. Brine soluble mercurochloro complex. Experiments were conducted to estimate global kinetics and interfacial mass transfer mud of a chlor-alkali industry containing elemental mercury parameters of the reaction between elemental mercury and and its salts is a solid waste and is usually dumped off-site in a aqueous sodium hypochlorite. The reaction did not conform to lined pond. Sometimes this brine mud is treated with aqueous either pure mass transfer or pure instantaneous reaction sodium hypochlorite to remove toxic mercury from the sludge. regimes. The order and activation energy of the reaction were This is a solid-liquid reaction and involves mass transfer of -1 estimated to be 1.168 and 13.48 kJ mol respectively. mercury from the solid matrix into a liquid phase. Sizeneva et Experimental data on reaction enhancement factors may be used al. [10] studied oxidative dissolution of Hg0 in NaOCl at pH for design of an industrial solid waste detoxification reactor. 0 0 5.9, 6.5, 6.9 and 8.5 at 25 C and 50 C.
    [Show full text]
  • Identification of Drug Candidates That Enhance Pyrazinamide Activity from a Clinical Drug Library
    bioRxiv preprint doi: https://doi.org/10.1101/113704; this version posted March 4, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Identification of drug candidates that enhance pyrazinamide activity from a clinical drug library Hongxia Niub, a, Chao Mac, Peng Cuid, Wanliang Shia, Shuo Zhanga, Jie Fenga, David Sullivana, Bingdong Zhu b, Wenhong Zhangd, Ying Zhanga,d* a Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA b Lanzhou Center for Tuberculosis Research and Institute of Pathogenic Biology, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China c College of Biological Sciences and Technology, Beijing Forestry University, Beijing 100083, China d Key Laboratory of Medical Molecular Virology, Department of Infectious Diseases, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China *Correspondence: Ying Zhang, E-Mail: [email protected] Tuberculosis (TB) remains a leading cause of morbidity and mortality globally despite the availability of the TB therapy. 1 The current TB therapy is lengthy and suboptimal, requiring a treatment time of at least 6 months for drug susceptible TB and 9-12 months (shorter Bangladesh regimen) or 18-24 months (regular regimen) for multi-drug-resistant tuberculosis (MDR-TB). 1 The lengthy therapy makes patient compliance difficult, which frequently leads to emergence of drug-resistant strains. The requirement for the prolonged treatment is thought to be due to dormant persister bacteria which are not effectively killed by the current TB drugs, except rifampin and pyrazinamide (PZA) which have higher activity against persisters.
    [Show full text]